CLINICAL_TRIALS trial_result · 2025-10-27

Clinical Trial Update: P1101 in Treating Patients With Myelofibrosis [Phase 2]

A Phase 2 trial of P1101 for primary and secondary myelofibrosis has been terminated. Results from the trial were posted on 2025-10-27.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Mayo Clinic | Conditions: Primary Myelofibrosis, Secondary Myelofibrosis | Phase 2 | Status: TERMINATED | Results posted: 2025-10-27